This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Cramer's Action Alerts PLUS - See his portfolio and get alerts BEFORE every trade. Learn more NOW!

Biopharmaceutical Managed Care Strength Closely Intertwined With Marketplace Success

CHAPEL HILL, N.C., April 19, 2013 /PRNewswire/ -- Managed care operations in the pharmaceutical sector are rapidly growing and have emerged as essential factors for success in the U.S. healthcare marketplace. Due to this rapid growth, pharmaceutical and medical device leaders have placed an increased importance on managed care activities.

While well-planned and executed managed care activities can yield sizeable returns, leaders must adapt and constantly adjust their resource levels to suit marketplace requirements. By observing the managed care activities and resourcing of major biopharmaceutical companies in the United States, executives can assess the efficiency and effectiveness of their managed care groups.

To meet the needs of leaders trying to defend their Managed Care resources and investment levels, research and consulting firm, Best Practices, LLC, conducted a primary research study on the issue. The ensuing report, " Resource Benchmarks for U.S. Pharmaceutical Managed Care Operations," delivers insights into the most effective Managed Care operations, tactics, and activities. It also provides a recent look at staffing and resourcing levels in Managed Care groups of leading U.S. pharmaceutical and biotechnology companies.

Key study topics include:

  • Overall Staffing Levels
  • Outsourcing Levels
  • Staffing Levels Per Key Activity
  • Staffing Levels Linked to Brands Supported
  • Financial Investment for U.S. Managed Care Group and Key Activities
  • Staffing Efficiency Measures

The full report contains more than 110 benchmark metrics and critical best practices and identifies industry standards for staffing, outsourcing, budget, and efficiency metrics. Collected benchmarks focused exclusively on interviews with 12 participating executives from leading companies across the pharmaceutical, biotech and medical device industries.

For more information on this study or other recent primary research studies, contact us at 919.403.0251 or visit our website at Best Practices, LLC. Check out Best Practices' blog at www.whybenchmarking.com.

ABOUT BEST PRACTICES, LLCBest Practices, LLC is a leading benchmarking, consulting and advisory services firm serving biopharmaceutical and medical device companies worldwide. Best Practices, LLC's clients include all the top 10 and 48 of the top 50 global healthcare companies. The firm conducts primary research and consulting using its comprehensive proprietary benchmarking tools and analysis. The operational insights, findings and analysis form the basis for our Benchmarking Reports, databases and advisory services to support executives in commercial and R&D operations.

SOURCE Best Practices, LLC

Copyright 2011 PR Newswire. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Try it NOW
Only $9.95
Try it NOW
14-Days Free
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 17,926.20 -209.52 -1.16%
S&P 500 2,076.98 -24.06 -1.15%
NASDAQ 4,937.0330 -45.7760 -0.92%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs